Inovio Pharmaceuticals (INO) Prices Offering of Common Stock and Warrants
Tweet Send to a FriendGet Alerts INO Hot Sheet
Up)
Trade INO Now!
Inovio Pharmaceuticals, Inc. (NYSE: INO) priced an underwritten offering of 27,377,266 shares of its common stock and warrants to purchase up to 13,688,633 shares of common stock at a combined price to the public of $0.55 per share and related warrant for gross proceeds of $15.1 million. The warrants are exercisable at an exercise price of $.7936 per share and will expire, unless exercised, on the date that is 180 days after the fifth anniversary of the date of issuance.
Inovio intends to use the net proceeds received from the sale of the securities (including any resulting from the exercise of the warrants) for general corporate purposes, including clinical trial expenses, research and development expenses, general and administrative expenses, manufacturing expenses and potential acquisitions of companies and technologies that complement our business.
Cowen and Company, LLC is acting as sole book-running manager for the offering. Brean Capital, LLC is acting as co-lead manager for the offering. Maxim Group LLC is acting as co-manager.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Inovio intends to use the net proceeds received from the sale of the securities (including any resulting from the exercise of the warrants) for general corporate purposes, including clinical trial expenses, research and development expenses, general and administrative expenses, manufacturing expenses and potential acquisitions of companies and technologies that complement our business.
Cowen and Company, LLC is acting as sole book-running manager for the offering. Brean Capital, LLC is acting as co-lead manager for the offering. Maxim Group LLC is acting as co-manager.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Inovio Pharmaceuticals (INO) Up on Positive H7N9 Flu Response in Preclinical Study
- Weyerhaeuser (WY) Prices 29M Offering at $27.75/Share
- SolarCity (SCTY) Files $175M Convertible Senior Notes Shelf
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Maxim Group, Cowen & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
